Keywords: procoralan, cuts, risk, cv, events, added, optimal

Procoralan cuts risk of CV events when added to optimal therapy

Article | 08 September 2008

Print This

The results of the BEAUTIFUL trial show that coronary artery disease patients with left ventricular dysfunction and a heart rate ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in